x

Posted 09 January, 2023

NEVRO CORP appointed new CEO

CEO Change detected for ticker NYSE:NVRO in a 8-K filed on 09 January, 2023.


  On January 9, 2023, the Company announced that Mr. D. Keith Grossman has informed the Board of Directors of the Company of his intention to retire as the Company's Chief Executive Officer and President in 2023 following the selection of his successor.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of NEVRO CORP
Health Care/Life Sciences • Medical Equipment/Supplies
Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Market Cap
$528M
View Company Details
NEVRO CORP by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 9, 2023, the Company announced that Mr. D. Keith Grossman has informed the Board of Directors of the Company of his intention to retire as the Company's Chief Executive Officer and President in 2023 following the selection of his successor. Mr. Grossman will remain in his role as Chairman of the Board.